Next-generation rotavirus vaccines: important progress but work still to be done
Julie E Bines, Karen L Kotloff
The Lancet Infectious Diseases | ELSEVIER SCI LTD | Published : 2020
JEB is lead of the RV3 Rotavirus Program at Murdoch Children's Research Institute (MCRI); MCRI is providing RV3-BB vaccine for a future clinical trial of parenteral trivalent P2-VP8 vaccine sponsored by PATH. KLK declares no competing interests.